Group II phospholipases A2 are indirectly cytolytic in the presence of exogenous phospholipid

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1346, Issue 2, 1997, Pages 193-197

  Vadas, Peter ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cytotoxicity; Erythrocyte; Phospholipase A2; Phospholipid; U937 cell

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPID;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; SEPTIC SHOCK;

CELL SURVIVAL; CHROMIUM; ERYTHROCYTES; HEMOLYSIS; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASES A; PHOSPHOLIPIDS; RECOMBINANT PROTEINS; SNAKE VENOMS; TUMOR CELLS, CULTURED;

EID: 0031548852     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(97)00029-5     Document Type: Article

References (18)

1. [1] Vadas, P. and Pruzanski, W. (1993) Circ. Shock 39, 160-167.
2. [2] Vadas, P., Pruzanski, W., Stefanski, E., Sternby, B., Mustard, R., Bohnen, J., Fraser, I., Farewell, V. and Bombardier, C. (1988) Crit. Care. Med. 16, 1-7.
3. [3] Sorensen, J., Kald, B., Tagesson, C. and Lindahl, M. (1994) Intens. Care Med. 20, 555-561.
4. [4] Ensenauer, R., Puttmann, M., Quintel, M., Kattermann, R. and Aufenanger, (1994) J. Clin. Invest. 72, 843-849.
5. [5] Mason, G.R. and Lin, H.C. (1979) J. Surg. Res. 27, 124-133.
6. [6] Bursten, S.L., Federighi, D.A., Parsons, P.E., Harris, W.E., Abraham, E., Moore, E.E., Moore, F.A., Bianco, J.A., Singer, J.W. and Repine, J.E. (1996) Crit. Care Med. 24, 1129-1136.
7. [7] Ransac, S., Aarsman, A.J., Van den Bosch, H., Gancet, C., De Haas, G.H. and Verger, R. (1992) Eur. J. Biochem. 204, 793-797.
8. [8] Vadas, P., Browning, J., Edelson, J. and Pruzanski, W. (1993) J. Lipid Med. 8, 1-30.
9. [9] Vadas, P., Schouten, B.D., Stefanski, E., Scott, K. and Pruzanski, W. (1993) Crit. Care Med. 21, 1087-1091.
10. [10] Dennis, E.A. (1994) J. Biolog. Chem. 269, 13057-13060.
11. [11] Weinrauch, Y., Elsbach, P., Madsen, L.M., Foreman, A. and Weiss, J. (1996) J. Clin. Invest. 97, 250-257.
12. [12] Morgan, D.W., Anderson, C.M. and Meyers, K.P. (1993) Eur. J. Pharmac. 235, 45-50.
13. [13] Moll, G.N., Vial, H.J., Severs, E.M., Ancelin, M.L., Roelofsen, B., Comfurius, P., Slotboom, A.J., Zwaal, R.F., Op den Kamp, J.A. and Van Deenen, L.L. (1990) Biochem. Cell Biol. 68, 579-585.
14. [14] Vernon, L.P. and Bell, J.D. (1992) Pharmac. Ther. 54, 269-295.
15. [15] Fletcher, J.E. and Jiang, M.-S. (1993) Toxicon 31, 669-695.
16. [16] Fourcade, O., Simon, M.F., Viode, C., Rugani, N., Leballe, F., Ragab, A., Fournie, B., Sarda, L. and Chap, H. (1995) Cell 80, 919-927.
17. [17] Bevers, E.M., Comfurius, P. and Zwaal, R.F. (1983) Biochim. Biophys. Acta 736, 57-66.
18. [18] Hara, S., Kudo, I. and Inoue, K. (1991) J. Biochem. 110, 163-165.